This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
All NIHB Plan Members Ages 2 Years and Older
Managing their Type 1 and Type 2 Diabetes with Insulin
are Eligible for Dexcom G6 Coverage
ADA 2023 Highlights: The Clinical and Economic Value of CGM – ManagedCareCGM.com – September 15, 2023
Latest Research in Diabetes Technology: Highlights from ATTD 2022 – ManagedCareCGM.com – July, 2022
ADA Standards of Medical Care: Recommendations for Continuous Glucose Monitoring – A Video Resource – ManagedCareCGM.com – May, 2022
The Value of rtCGM in Optimizing the Management of T2D – A Video Resource – ManagedCareCGM.com – January 2022
Lower A1c and Reduce Hospital/ED Use in Members with Insulin-Treated Type 2 Diabetes via Real-Time Continuous Glucose Monitoring – ManagedCareCGM.com – September 2021
FDA gives the go ahead for third-party developers to integrate real-time CGM data into their digital health apps and devices. – Business Wire – July 2021
Optimize Outcomes in Insulin-Treated T1 and T2D via Evidence-Based Coverage Criteria with Real-Time Continuous Glucose Monitoring – ManagedCareCGM.com – June 2021
Improving Quality Metrics and Reducing Cost of Care with Access to Real-Time Continuous Glucose Monitoring – ManagedCareCGM.com – May 2021
Welldoc’s BlueStar, Dexcom G6 CGM to be offered as single diabetes platform – First World Health Tech – April 5, 2021